ScholarIQanswers from OpenAlex & ORCID
James F. Rooney
ResearcherPublications, citations & collaboration network
James F. Rooney is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James F. Rooney have?
ScholarIQindexed works
James F. Rooney has 212 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James F. Rooney have?
ScholarIQcitation count
James F. Rooney has 23,992 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James F. Rooney?
ScholarIQh-index
James F. Rooney has an h-index of 59 in OpenAlex.
What is the i10-index of James F. Rooney?
ScholarIQi10-index
James F. Rooney has an i10-index of 127 in OpenAlex.
What is the ORCID of James F. Rooney?
ScholarIQorcid
The ORCID for James F. Rooney is on the source record.
What is the OpenAlex record for James F. Rooney?
ScholarIQopenalex
The OpenAlex for James F. Rooney is on the source record.
What are the most-cited papers on James F. Rooney?
ScholarIQmost cited works
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
Rhoda Sperling, David E. Shapiro, Robert W. Coombs, John A. Todd, Steven A. Herman, George McSherry, Mary Jo O’Sullivan, Russell B. Van Dyke, Eleanor Jiménez, Christine Rouzioux, Patricia M. Flynn, John L. Sullivan, Stephen A. Spector, Clemente Díaz, James F. Rooney, James Balsley, Richard D. Gelber, Edward M. Connor
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
Kristine B. Patterson, Heather A. Prince, Eric Kraft, Amanda J. Jenkins, Nicholas J. Shaheen, James F. Rooney, Myron S. Cohen, Angela D. M. Kashuba
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Shahin Lockman, Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti, Patrick Jean‐Philippe, Ben Johnston, Chelsea Krotje, Lee Fairlie, Risa M. Hoffman, Paul E. Sax, Sikhulile Moyo, Nahida Chakhtoura, Jeffrey S. A. Stringer, Gaerolwe Masheto, Violet Korutaro, Haseena Cassim, Blandina T. Mmbaga, Esaú João, Sherika Hanley, Lynette Purdue, Lewis B. Holmes, Jeremiah D. Momper, Roger Shapiro, Navdeep Thoofer, James F. Rooney, Lisa M. Frenkel, K. Rivet Amico, Lameck Chinula, Judith S. Currier, Brookie M. Best, Cheryl Blanchette, Renee Browning, Yao Cheng, Andee Fox, Nagawa Jaliaah, Kevin Knowles, Mark Mirochnick, William Murtaugh, Emmanuel Patras, Mauricio Pinilla, Jean van Wyk, Frances Whalen